Viral Hepatitis

Top Story

Gilead joins ongoing NASH, HBV observational study initiative

November 20, 2018
Meeting News

Preemptive DAA therapy improves outcomes of negative-to-positive HCV heart transplant

November 16, 2018
SAN FRANCISCO — Preemptive administration of pangenotypic direct-acting antiviral therapy resulted in rapid viral suppression of hepatitis C in patients without…
Meeting News

EXPEDITION-8: Mavyret nearly perfect in 8-week regimen

November 13, 2018
SAN FRANCISCO — Mavyret yielded nearly perfect SVR rates after 8 weeks of therapy in compensated cirrhosis with HCV, according to data presented at The Liver…
Meeting News

NS5A substitutions affect early HCV treatment failures, retreatment

November 12, 2018
SAN FRANCISCO — NS5A resistance-associated substitutions at several positions, including Y93, may hold information about DAA treatment response, according to data…
More Headlines »
CME

Cirrhosis and Hepatic Encephalopathy – Managing Their Consequences and Complications

This activity is supported by an educational grant from Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC.

Cirrhosis, or advanced fibrosis of the liver, can lead to serious health sequelae or death. However, substantial…
More »
GI Bookshelf

Question 20: A 58-Year-Old Female Underwent A Screening Colonoscopy That Showed A 2.5-Cm Flat Polyp In The Proximal Ascending Colon. I Tattooed The Area And Biopsied The Polyp, Which Was Initially Reported As Hyperplastic. What Should I Do?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Video
Meeting News

VIDEO: Expert reviews promising treatment data from The Liver Meeting 2017

October 25, 2017
More »